Publicacions (23) Publicacions de MARTA VICARIO DE LA TORRE

2024

  1. Enhancing the hypotensive effect of latanoprost by combining synthetic phosphatidylcholine liposomes with hyaluronic acid and osmoprotective agents

    Drug Delivery and Translational Research, Vol. 14, Núm. 10, pp. 2804-2822

  2. Physicochemical stability of bortezomib solutions for subcutaneous administration

    Scientific Reports, Vol. 14, Núm. 1

  3. Smart biodegradable hydrogels: Drug-delivery platforms for treatment of chronic ophthalmic diseases affecting the back of the eye

    International Journal of Pharmaceutics, Vol. 649

  4. Topical Insulin Eye Drops: Stability and Safety of Two Compounded Formulations for Treating Persistent Corneal Epithelial Defects

    Pharmaceutics, Vol. 16, Núm. 5

2023

  1. Desarrollo de microemulsiones de administración tópicaocular como plataforma para el tratamiento o prevención dela enfermedad de ojo seco

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  2. Desarrollo de una formulación antiglaucomatosa tópica a partir de una lágrima artificial

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  3. Long-acting hybrid microemulsion for the simultaneous treatment of glaucoma and ocular surface diseases

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  4. Microesferas biodegradables de liberación controlada de agentes antioxidantes y anti-inflamatorios como potencial terapia neuroprotectora para el glaucoma

    XVI Congreso SEFIG ( 16. 2023. Madrid): Libro de comunicaciones

  5. New trends towards glaucoma treatment: Topical osmoprotective microemulsions loaded with latanoprost

    Ocular Surface, Vol. 29, pp. 314-330

2022

  1. Comparison of the efficacy of topical insulin with autologous serum eye drops in persistent epithelial defects of the cornea

    Acta Ophthalmologica, Vol. 100, Núm. 4, pp. e912-e919

  2. Development of an osmoprotective microemulsion as a therapeutic platform for ocular surface protection

    International Journal of Pharmaceutics, Vol. 623

  3. Novel Osmoprotective DOPC-DMPC Liposomes Loaded with Antihypertensive Drugs as Potential Strategy for Glaucoma Treatment

    Pharmaceutics, Vol. 14, Núm. 7

  4. Validation of a Rapid and Easy-to-Apply Method to Simultaneously Quantify Co-Loaded Dexamethasone and Melatonin PLGA Microspheres by HPLC-UV: Encapsulation Efficiency and In Vitro Release

    Pharmaceutics, Vol. 14, Núm. 2

2018

  1. Novel Nano-liposome formulation for dry eyes with components similar to the preocular tear film

    Polymers, Vol. 10, Núm. 4

2017

  1. Novel anti-inflammatory liposomal formulation for the pre-ocular tear film: In vitro and ex vivo functionality studies in corneal epithelial cells

    Experimental Eye Research, Vol. 154, pp. 79-87

  2. The potential of stimuli-responsive nanogels in drug and active molecule delivery for targeted therapy

    Gels, Vol. 3, Núm. 2

2016

  1. Novel water-soluble mucoadhesive carbosilane dendrimers for ocular administration

    Molecular Pharmaceutics, Vol. 13, Núm. 9, pp. 2966-2976

2014

  1. Design and characterization of an ocular topical liposomal preparation to replenish the lipids of the tear film

    Investigative Ophthalmology and Visual Science, Vol. 55, Núm. 12, pp. 7839-7847

  2. Hybrid formulations of liposomes and bioadhesive polymers improve the hypotensive effect of the melatonin analogue 5-MCA-NAT in rabbit eyes

    PLoS ONE, Vol. 9, Núm. 10

  3. The potential of using biodegradable microspheres in retinal diseases and other intraocular pathologies

    Progress in Retinal and Eye Research, Vol. 42, pp. 27-43